The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright future

JM Foster, C Zhang, S Rehman… - CA: A Cancer …, 2023 - Wiley Online Library
Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …

Magnetic nanoparticles for hyperthermia in cancer treatment: an emerging tool

J Jose, R Kumar, S Harilal, GE Mathew… - … Science and Pollution …, 2020 - Springer
Cancer remains as the major cause of death worldwide. The main reason why available
therapies fail is that a vicious cycle in established which initiates multiple pathways and …

Recent advances in metal nanoparticles in cancer therapy

A Sharma, AK Goyal, G Rath - Journal of drug targeting, 2018 - Taylor & Francis
Metal nanoparticles (NPs) may have the potential to overcome problems related to
conventional chemotherapy. Metal NPs reported to play a beneficial and powerful role in …

Nanoparticle-mediated hyperthermia in cancer therapy

DK Chatterjee, P Diagaradjane, S Krishnan - Therapeutic delivery, 2011 - Taylor & Francis
A small rise in tumor temperature (hyperthermia) makes cancer cells more susceptible to
radiation and chemotherapy. The means of achieving this is not trivial, and traditional …

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience

TD Yan, M Deraco, D Baratti, S Kusamura… - Journal of Clinical …, 2009 - ascopubs.org
Purpose This multi-institutional registry study evaluated cytoreductive surgery (CRS)
combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for diffuse malignant …

Hyperthermia using nanoparticles–promises and pitfalls

P Kaur, ML Aliru, AS Chadha, A Asea… - International Journal of …, 2016 - Taylor & Francis
An ever-increasing body of literature affirms the physical and biological basis for
sensitisation of tumours to conventional therapies such as chemotherapy and radiation …

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis

JH Helm, JT Miura, JA Glenn, RK Marcus… - Annals of surgical …, 2015 - Springer
Background Due to the increased adoption of cytoreductive surgery (CRS) and hyperthermic
intraperitoneal chemotherapy (HIPEC), patients with malignant peritoneal mesothelioma …

[HTML][HTML] Hyperthermia: how can it be used?

Z Behrouzkia, Z Joveini, B Keshavarzi… - Oman medical …, 2016 - ncbi.nlm.nih.gov
Hyperthermia (HT) is a method used to treat tumors by increasing the temperature of the
cells. The treatment can be applied in combination with other verified cancer treatments …

Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients

EA Levine, JH Stewart IV, P Shen, GB Russell… - Journal of the American …, 2014 - Elsevier
Background Peritoneal dissemination of abdominal malignancy (carcinomatosis) has a
clinical course marked by bowel obstruction and death; it traditionally does not respond well …

[HTML][HTML] Malignant peritoneal mesothelioma: a review

J Kim, S Bhagwandin, DM Labow - Annals of translational medicine, 2017 - ncbi.nlm.nih.gov
Mesothelioma is a malignancy of serosal membranes. It is most commonly encountered in
the visceral pleura with the second most common location in the peritoneum. The diagnosis …